These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31128378)

  • 21. Acetazolamide and sulfonamide allergy: a not so simple story.
    Kelly TE; Hackett PH
    High Alt Med Biol; 2010; 11(4):319-23. PubMed ID: 21190500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Metabolism of Methazolamide in Immortalized Human Keratinocytes, HaCaT Cells.
    Sasabe T; Maeda S; Kishida K; Yamano M; Miwa Y; Sugiyama T
    Drug Metab Lett; 2017; 10(4):295-305. PubMed ID: 28137210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Associated with Carbonic Anhydrase Inhibitors: Epidemiology, Genetics, and Insights into Mechanisms.
    Trubiano JA; Ostrov DA; Phillips EJ
    J Allergy Clin Immunol Pract; 2019; 7(8):2854-2856. PubMed ID: 31706497
    [No Abstract]   [Full Text] [Related]  

  • 24. Carbonic anhydrase inhibitor side effects. Serum chemical analysis.
    Epstein DL; Grant WM
    Arch Ophthalmol; 1977 Aug; 95(8):1378-82. PubMed ID: 889513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium metabolism in acidotic patients induced by carbonic anhydrase inhibitors: responses to citrate.
    Higashihara E; Nutahara K; Takeuchi T; Shoji N; Araie M; Aso Y
    J Urol; 1991 May; 145(5):942-8. PubMed ID: 2016806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Organic impotence associated with carbonic anhydrase inhibitor therapy for glaucoma.
    Epstein RJ; Allen RC; Lunde MW
    Ann Ophthalmol; 1987 Feb; 19(2):48-50. PubMed ID: 3566023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
    East-Innis AD; Thompson DS
    West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary calculi with methazolamide therapy.
    Ellis PP
    Doc Ophthalmol; 1973 Feb; 34(1):137-42. PubMed ID: 4706085
    [No Abstract]   [Full Text] [Related]  

  • 29. Serious Adverse Events of Oral and Topical Carbonic Anhydrase Inhibitors.
    Popovic MM; Schlenker MB; Thiruchelvam D; Redelmeier DA
    JAMA Ophthalmol; 2022 Mar; 140(3):235-242. PubMed ID: 35084437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study.
    Frey N; Bodmer M; Bircher A; Jick SS; Meier CR; Spoendlin J
    Drug Saf; 2019 Jan; 42(1):55-66. PubMed ID: 30112729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
    Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aetiology in sixteen cases of toxic epidermal necrolysis and Stevens-Johnson syndrome admitted within eight months in a teaching hospital.
    Yeung CK; Ma SY; Hon C; Peiris M; Chan HH
    Acta Derm Venereol; 2003; 83(3):179-82. PubMed ID: 12816151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Stevens-Johnson syndrome and toxic epidermal necrolysis: retrospective study of 185 cases in Abidjan (Côte d'Ivoire)].
    Kourouma S; Sangaré A; Kaloga M; Kouassi I; Ecra E; Gbery I; Ahogo C; Kouassi A; Kassi K; Camara B
    Med Sante Trop; 2014; 24(1):94-8. PubMed ID: 24736218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methazolamide-induced delirium.
    Cyr M; Laizure SC; daCunha CM
    Pharmacotherapy; 1997; 17(2):387-9. PubMed ID: 9085335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive assessment of T cell receptor β repertoire in Stevens-Johnson syndrome/toxic epidermal necrolysis patients using high-throughput sequencing.
    Xiong H; Wang L; Jiang M; Chen S; Yang F; Zhu H; Zhu Q; Tang C; Qin S; Xing Q; Luo X
    Mol Immunol; 2019 Feb; 106():170-177. PubMed ID: 30623817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
    Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glaucoma with modified osteo-odonto keratoprosthesis.
    Iyer G; Srinivasan B
    Cornea; 2012 Sep; 31(9):1092. PubMed ID: 22699560
    [No Abstract]   [Full Text] [Related]  

  • 39. Identifying the incidence of rash, Stevens-Johnson syndrome and toxic epidermal necrolysis in patients taking lamotrigine: a systematic review of 122 randomized controlled trials.
    Bloom R; Amber KT
    An Bras Dermatol; 2017; 92(1):139-141. PubMed ID: 28225977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methazolamide and acetazolamide in acute mountain sickness.
    Wright AD; Bradwell AR; Fletcher RF
    Aviat Space Environ Med; 1983 Jul; 54(7):619-21. PubMed ID: 6349608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.